Form 4: Sabra Health Care REIT Executive VP, CIO & Treasurer Talya Nevo-Hacohen Reports Changes in Beneficial Ownership
SEC Form 4 Filing
Talya Nevo-Hacohen, Executive VP, CIO & Treasurer of Sabra Health Care REIT, reports acquisition of 4,874 shares of common stock due to dividend equivalent payments and adjustments to holdings in a trust.
Summary
- On February 28, 2025, Talya Nevo-Hacohen, Executive VP, CIO & Treasurer of Sabra Health Care REIT, acquired 4,874 shares of common stock.
- This acquisition is attributed to dividend equivalent payments on previously granted stock units under the company's 2009 Performance Incentive Plan.
- The dividend equivalent payments are calculated based on the market value of Sabra Health Care REIT's common stock on the dividend payment date.
- These stock units will vest and become payable under the same terms as the original stock units.
- Following the reported transactions, Nevo-Hacohen directly owns 326,881 shares and indirectly owns 529,206 shares through The Talya Nevo-Hacohen Trust.
- The filing also indicates that 274,851 of the directly owned shares are stock units that will be settled on a one-for-one basis in shares of the Issuer's Common Stock.
Sentiment
Score: 6
Explanation: The document is a standard regulatory filing, indicating neutral sentiment. It reflects routine transactions related to executive compensation and holdings.
Positives
- The acquisition of shares through dividend equivalent payments reflects the company's commitment to its incentive plan.
- The increase in holdings demonstrates the reporting person's continued investment in the company.
Industry Context
Form 4 filings are standard practice for reporting changes in beneficial ownership by company insiders, providing transparency to investors.
Stakeholder Impact
- The filing provides transparency to shareholders regarding insider transactions.
- The dividend equivalent payments reflect the company's commitment to its executive compensation plan, potentially impacting employee morale.
Key Dates
| Date | Description |
|---|---|
| 02/28/2025 | Date of the transaction (acquisition of shares). |
| 03/04/2025 | Date of signature by Attorney-in-Fact. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.